SonoScape Medical Corp (300633) — Capital Reinvestment Ratio

Latest as of June 2025: 0.88x

SonoScape Medical Corp (300633) has a Capital Reinvestment Ratio of 0.88x as of June 2025, meaning it reinvests 1% of its operating cash flow (CN¥34.57 Million) in capital expenditures (CN¥30.33 Million). See 300633 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.88x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥34.57 Million
CNY

Capital Expenditures

CN¥30.33 Million
CNY

Data as of

Jun 2025
Most recent filing

SonoScape Medical Corp Capital Reinvestment Ratio (2012–2024)

This chart tracks SonoScape Medical Corp's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for SonoScape Medical Corp (2012–2024)

Year-by-year Capital Reinvestment Ratio for SonoScape Medical Corp from 2012 to 2024. For live market cap and broader valuation context, see how much is SonoScape Medical Corp worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.67x CN¥306.66 Million CN¥206.86 Million ▲ +88.2%
2023 0.36x CN¥493.88 Million CN¥176.99 Million ▼ -10.9%
2022 0.40x CN¥473.26 Million CN¥190.32 Million ▼ -20.0%
2021 0.50x CN¥302.99 Million CN¥152.25 Million ▼ -12.3%
2020 0.57x CN¥271.13 Million CN¥155.29 Million ▼ -31.3%
2019 0.83x CN¥190.39 Million CN¥158.79 Million ▲ +140.9%
2018 0.35x CN¥233.65 Million CN¥80.88 Million ▲ +4.0%
2017 0.33x CN¥136.21 Million CN¥45.35 Million ▲ +229.3%
2016 0.10x CN¥137.38 Million CN¥13.89 Million ▼ -64.9%
2015 0.29x CN¥56.29 Million CN¥16.21 Million ▲ +96.9%
2014 0.15x CN¥113.55 Million CN¥16.60 Million ▼ -73.3%
2013 0.55x CN¥89.94 Million CN¥49.25 Million ▼ -62.1%
2012 1.45x CN¥15.49 Million CN¥22.41 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow